EatDrama
Entertainment

STAT Plus: FDA expert panel recommends against approval of Capricor’s Duchenne drug

STAT Plus: FDA expert panel recommends against approval of Capricor’s Duchenne drug

FDA panel cites 'fragile' data, deals blow to Duchenne patient community in declining to recommend approval of Capricor's Duchenne drug deramiocel.

Open original source

Featured Creators

Creators building their communities through the SpiderTaz Creator Program.

View creators →